Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Capital Expenditures (2022 - 2025)

Praxis Precision Medicines (PRAX) has 3 years of Capital Expenditures data on record, last reported at -$8000.0 in Q2 2025.

  • For Q2 2025, Capital Expenditures changed N/A year-over-year to -$8000.0; the TTM value through Dec 2025 reached $56000.0, changed N/A, while the annual FY2025 figure was $56000.0, N/A changed from the prior year.
  • Capital Expenditures reached -$8000.0 in Q2 2025 per PRAX's latest filing, down from $64000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $444000.0 in Q4 2022 and bottomed at -$399000.0 in Q3 2022.
  • Average Capital Expenditures over 3 years is $78571.4, with a median of $64000.0 recorded in 2025.
  • The widest YoY moves for Capital Expenditures: up 112.53% in 2023, down 112.53% in 2023.
  • A 3-year view of Capital Expenditures shows it stood at $444000.0 in 2022, then plummeted by 88.74% to $50000.0 in 2023, then tumbled by 116.0% to -$8000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$8000.0 in Q2 2025, $64000.0 in Q1 2025, and $50000.0 in Q3 2023.